CD44 and prostate carcinoma: In contrast, another study of CD44 isoform expression in prostate cancer concluded that CD44s promoted tumour initiation, cell proliferation, invasion and migration, providing evidence of the correlation between total CD44 expression and prostate cancer progression for CD44s only.